ICU Relative Valuation
ICU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ICU is overvalued; if below, it's undervalued.
Historical Valuation
SeaStar Medical Holding Corp (ICU) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.89. The fair price of SeaStar Medical Holding Corp (ICU) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：0.36
Fair
-0.82
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
SeaStar Medical Holding Corp. (ICU) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.09
EV/EBIT
SeaStar Medical Holding Corp. (ICU) has a current EV/EBIT of 0.09. The 5-year average EV/EBIT is -1.11. The thresholds are as follows: Strongly Undervalued below -4.78, Undervalued between -4.78 and -2.95, Fairly Valued between 0.72 and -2.95, Overvalued between 0.72 and 2.56, and Strongly Overvalued above 2.56. The current Forward EV/EBIT of 0.09 falls within the Historic Trend Line -Fairly Valued range.
8.49
PS
SeaStar Medical Holding Corp. (ICU) has a current PS of 8.49. The 5-year average PS is 25.87. The thresholds are as follows: Strongly Undervalued below -72.64, Undervalued between -72.64 and -23.38, Fairly Valued between 75.12 and -23.38, Overvalued between 75.12 and 124.38, and Strongly Overvalued above 124.38. The current Forward PS of 8.49 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
SeaStar Medical Holding Corp. (ICU) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.38. The thresholds are as follows: Strongly Undervalued below -2.20, Undervalued between -2.20 and -1.29, Fairly Valued between 0.54 and -1.29, Overvalued between 0.54 and 1.45, and Strongly Overvalued above 1.45. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
SeaStar Medical Holding Corp. (ICU) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
SeaStar Medical Holding Corp (ICU) has a current Price-to-Book (P/B) ratio of 1.07. Compared to its 3-year average P/B ratio of -1.07 , the current P/B ratio is approximately -200.24% higher. Relative to its 5-year average P/B ratio of -6.31, the current P/B ratio is about -116.93% higher. SeaStar Medical Holding Corp (ICU) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -90.28%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -87.42% , the current FCF yield is about -100.00% lower.
1.07
P/B
Median3y
-1.07
Median5y
-6.31
-115.85
FCF Yield
Median3y
-90.28
Median5y
-87.42
Competitors Valuation Multiple
The average P/S ratio for ICU's competitors is , providing a benchmark for relative valuation. SeaStar Medical Holding Corp Corp (ICU) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 169.12%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ICU decreased by 81.49% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 68.00K to 183.00K.
The secondary factor is the Margin Expansion, contributed -71.19%to the performance.
Overall, the performance of ICU in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is SeaStar Medical Holding Corp (ICU) currently overvalued or undervalued?
What is SeaStar Medical Holding Corp (ICU) fair value?
How does ICU's valuation metrics compare to the industry average?
What is the current P/B ratio for SeaStar Medical Holding Corp (ICU) as of Dec 05 2025?
What is the current FCF Yield for SeaStar Medical Holding Corp (ICU) as of Dec 05 2025?
What is the current Forward P/E ratio for SeaStar Medical Holding Corp (ICU) as of Dec 05 2025?